NCT03684694 2024-02-06Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell LymphomaADC Therapeutics S.A.Phase 1/2 Terminated136 enrolled 33 charts